Almirall is a pharmaceutical company dedicated to providing innovative drugs around the world. The aim of the company is to achieve a leading position on the dermatologic and respiratory system diseases’ markets and growth in gastroenterology and central nervous system markets. The company’s portfolio covers products developed by an own R&D unit as well as licensed as a result of cooperation with business partners. Almirall has 13 divisions located in over 70 countries around the world.